daunorubicin has been researched along with Cystadenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dezsö, B; Rosik, LO; Sweet, F; Török, I | 1 |
| Lazo, JS; Schwartz, PE | 1 |
2 other study(ies) available for daunorubicin and Cystadenocarcinoma
| Article | Year |
|---|---|
Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: an immunofluorescence study.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Cystadenocarcinoma; Daunorubicin; Drug Carriers; Female; Fluorescent Antibody Technique; Humans; Immunotoxins; Ovarian Neoplasms | 1990 |
Rapid distribution of adriamycin in the ascitic and pleural fluid of women with ovarian carcinomas.
Topics: Ascitic Fluid; Chromatography, High Pressure Liquid; Cystadenocarcinoma; Daunorubicin; Doxorubicin; Female; Humans; Kinetics; Middle Aged; Naphthacenes; Ovarian Neoplasms; Pleural Effusion; Reference Standards | 1985 |